To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Pure Versus Leukocyte Platelet-Rich Plasma Intra-Articular Injections for Knee Cartilage Lesions

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
June 2023

Pure Versus Leukocyte Platelet-Rich Plasma Intra-Articular Injections for Knee Cartilage Lesions

Vol: 303| Issue: 6| Number:7| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Clinical Efficacy of Intra-Articular Injection with P-PRP Versus that of L-PRP in Treating Knee Cartilage Lesion: A Randomized Controlled Trial.

Orthop Surg. 2023 Mar; 15(3): 740–749.

Contributing Authors:
Y Zhou H Li S Cao Y Han J Shao Q Fu B Wang J Wu D Xiang Z Liu H Wang J Zhu Q Qian X Yang S Wang

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Sixty patients with knee cartilage lesions were randomized to receive either an intra-articular injection with pure platelet-rich plasma (P-PRP; n=30) or with leukocyte-rich platelet-rich plasma (L-PRP; n=30). Outcomes of interest included Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain, stiffness, and function as well as pain at rest and with movement measured on a Vis...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue